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Abstract 
Brain death (BD) should be understood as
the  ultimate  clinical  expression  of  a  brain
catastrophe characterized by a complete and
irreversible neurological stoppage, recognized
by irreversible coma, absent brainstem reflex-
es, and apnea. The most common pattern is
manifested  by  an  elevation  of  intracranial
pressure to a point beyond the mean arterial
pressure, and hence cerebral perfusion pres-
sure falls and, as a result, no net cerebral blood
flow is present, in due course leading to per-
manent  cytotoxic  injury  of  the  intracranial
neuronal  tissue.  A  second  mechanism  is  an
intrinsic injury affecting the nervous tissue at
a  cellular  level  which,  if  extensive  and
unremitting, can also lead to BD. We review
here  the  methodology  of  diagnosing  death,
based on finding any of the signs of death. The
irreversible loss of cardio-circulatory and res-
piratory functions can cause death only when
ischemia and anoxia are prolonged enough to
produce  an  irreversible  destruction  of  the
brain. The sign of such loss of brain functions,
that is to say BD diagnosis, is fully reviewed.
Introduction
Long  before  modern  technology,  everyone
agreed  that  death  occurred  when  heartbeat
and breathing ceased, and the soul abandoned
the body. Nonetheless, a new concept of death
evolved as technology progressed, forcing med-
icine and society to redefine the ancient car-
dio-respiratory  diagnosis  to  a  neurocentric
diagnosis  of  death.
1-4 In  the  meantime,  the
technical and scientific advances of the last
century provided effective mechanical ventila-
tors,  and  cardiopulmonary  resuscitation
(“reanimation”) compelled physicians in the
late 1950s to confront a condition impossible
even to imagine previously, a state in which
the brain is massively damaged and nonfunc-
tional while other organs remain functioning.
Was such a patient alive or dead? This radical-
ly  changed  the  course  of  the  debates  about
human death, marking a turning point when
brain-oriented definitions of death started to
be formulated, and brain death (BD) was grad-
ually  accepted  as  death  of  the  individual.
5-12
However, it is commonly believed that the con-
cept of BD evolved to benefit organ transplan-
tation. A historical approach demonstrates that
both brain death and transplantation had fully
separate  origins.  Organ  transplantation
became  possible  with  technical  advances  in
surgery  and  immunosuppressive  treatment.
The concept of BD evolved with the introduc-
tion of intensive care units.
12,13
BD  should  be  understood  as  the  ultimate
clinical expression of a brain catastrophe lead-
ing to a complete and irreversible neurological
stoppage, characterized by irreversible coma,
absent brainstem reflexes, and apnea.
14 Most
authors affirm that the diagnosis of BD is just
a clinical assessment, and after the Harvard
Committee  Report,
15,16 most  countries  and
states  designed  their  BD  diagnostic  crite-
ria.
6,7,17-21 BD diagnosis should be carried out
following a certain set of principles; that is to
say, excluding major confusing factors, estab-
lishing  the  cause  of  the  coma,  determining
irreversibility, and precisely testing brainstem
reflexes at all levels of the brainstem.
22
Pathophysiology of brain
death
Increased  intracranial  pressure  (ICP)  is
considered  the  most  important  pathophysio-
logical mechanism of BD leading to a complete
cessation of intracranial blood flow. Upholding
of  oxygenation  and  hemodynamics  by  vaso-
pressor drugs as well as mechanical ventila-
tion  can  sustain  somatic  organs  while  the
brain  suffers  an  ongoing  necrosis  process.
However, this is not the only pathophysiologi-
cal  mechanism  of  BD.
1,23 Palmer  and  Bader
studied a series of brain-dead patients by brain
tissue oxygenation (PbtO2) and described two
pathophysiological patterns regarding cerebral
blood flow (CBF).
23,24 The most common pattern
is manifested by an elevation of ICP to a point
beyond the mean arterial pressure (MAP), and
hence cerebral perfusion pressure (CPP) falls
to zero and, as a result, no net CBF is present,
in due course leading to permanent cytotoxic
injury of the intracranial neuronal tissue. 
In  addition,  there  may  be  circumstances
where an ICP increment does not lead to CBF
cessation. This may occur when ICP augmen-
tation  is  compensated  in  infants  with  open
fontanelles and soft, deformable skulls, and in
patients whose skulls are open owing to multi-
ple fractures, ventricular drainage, or decom-
pressive  craniectomy.
25-35 Moreover,  diffuse
intracranial parenchymal swelling is the main
reason  for  a  markedly  elevated  ICP,  but
swelling is not an indefinite phenomenon, and
it may decrease progressively, and if MAP is
maintained at reasonable values, CBF might
ultimately return.
25,28
The second pattern described by Palmer and
Bader  is  characterized  by  preserved  CBF,
because normal ICP does not exceed MAP, and
sufficient CPP is maintained leading to CBF
preservation, which supplies the nervous tis-
sue with necessary oxygen, glucose, and nutri-
ents to permit its survival.
24 In this pattern the
mechanism causing PbtO2 to fall to zero is an
intrinsic catastrophe affecting the nervous tis-
sue at a cellular level which, if extensive and
unremitting, can also lead to BD.
23,25,36 It is clear
that in this pattern the lack of oxygenation of
the brain is not a failure of the delivery system,
and hence it stands for end organ breakdown
of the brain at the capillary or tissue level.
23,36
Diagnosis of brain death
BD diagnosis should be carried out follow-
ing a certain set of principles;
6,21,37-46 that is to
say, excluding major confusing factors, estab-
lishing  the  cause  of  the  coma,  determining
irreversibility, and precisely testing brainstem
reflexes  at  all  levels  of  the  brainstem.
47
Nonetheless, most criteria for BD diagnosis do
not mention that this is not the only way of
diagnosing death. If a concept of death on neu-
rological grounds is accepted, then BD diag-
nostic criteria can be applied only in patients
under life support assistance in ICUs. Does it
mean that when a physician diagnoses death
in a regular ward (the patient is not under life
support), applying cardio-circulatory and respi-
ratory diagnostic criteria, or when a forensic
specialist  diagnoses  death  in  a  body  under
criminal  circumstances,  we  are  denying  a
brain-oriented concept of death?
1,48
Recently  Cuba  has  passed  a  law  for  the
determination and certification of death. The
National  Commission  for  the  Determination
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logical view of death and emphasized that any
legislation of death should be completely sepa-
rated from any norm governing organ trans-
plants.
49-52 Hence, the Commission enumerated
three possible situations for diagnosing death: 
i) Outside the intensive care environment
(without  life  support),  physicians  apply  the
cardio-circulatory and respiratory criteria.
ii)  In  forensic  medicine  circumstances,
physicians  utilize  cadaveric  signs.  (They  do
not even need a stethoscope.)
iii) In the intensive care environment (with
life  support)  when  cardio-circulatory  and/or
respiratory  arrest  occurs,  physicians  utilize
the cardio-circulatory and respiratory criteria.
When physicians suspect an irreversible loss
of brain functions in a heart-beating and ven-
tilatory supported case, BD diagnostic criteria
are applied.
This  methodology  of  diagnosing  death,
based on finding any of the signs of death, is
not related to the concept that there are differ-
ent types of death. The irreversible loss of car-
dio-circulatory  and  respiratory  functions  can
cause death only when ischemia and anoxia
are  prolonged  enough  to  produce  an  irre-
versible destruction of the brain. According to
the  Commission,  there  is  only  one  kind  of
death, based on the irreversible loss of brain
functions.
1,48-52
Signs of death
The diagnosis of death was based on the
finding of any of the following signs of death: 
I Irreversible loss of respiratory function.
II Irreversible loss of cardio-circulatory func-
tions.
III Algor mortis (postmortem coldness).
IV Livor mortis (postmortem lividity).
V Rigor mortis (postmortem rigidity).
VI Cadaveric spasm.
VII Loss of muscle contractions.
VIII Putrefaction.
IX Irreversible loss of brain functions.
Signs I and II correspond to the classical res-
piratory  and  cardio-circulatory  functions.
Signs III to VIII are related to forensic circum-
stances, and beyond the scope of this review.
Irreversible loss of brain functions
(diagnosis of brain death)
As  has  already  been  emphasized,  when
physicians suspect an irreversible loss of brain
functions  in  a  heart-beating  and  ventilatory
supported  case,  BD  diagnostic  criteria  are
applied. To assess brain functions during BD
diagnosis, the clinical neurological examina-
tion is the accepted standard.
8,12,13,22,48,52-54
Preconditions or pre-requisites
1. Coma owing to irreversible acute brain
damage  of  known  etiology,  affecting  both
hemispheres and brainstem. What is demand-
ed is to have clear and definite clinical and/or
neuroimaging  evidence  of  an  acute  central
nervous system (CNS) insult that is consistent
with the irreversible loss of neurological func-
tion.
1,7,22,47,55
2. At the time of beginning the neurological
examination,  it  is  essential  to  exclude  con-
founding factors that mimic BD:
1,22,56,57
Unresuscitated shock. This is indispensable
to applied BD criteria only when blood pres-
sure has a minimum value of 90 mm Hg.
22,58-62
Hypothermia (core temperature <34°C). An
inability to regulate temperature, or poikilo-
thermia, is often present in BD. Core tem-
perature results should be obtained through
central blood, rectal, esophageal, or gastric
measurement. Most sets of criteria for BD
diagnosis demand a body temperature of at
least 32.2°C.
1,17,22,43,55,61-64
Severe metabolic disorders capable of caus-
ing  a  potentially  reversible  coma.  Severe
metabolic or endocrine abnormalities make
BD unreliable.
22,55-57,65 Metabolic or endocrine
derangement including glucose, electrolytes
(including phosphate, calcium, and magne-
sium), inborn errors of metabolism, liver or
renal dysfunction, etc. may cause a poten-
tially reversible coma.
1,22
Peripheral nerve or muscle dysfunction and
neuromuscular  blockade potentially  play  a
role  in  inducing  unresponsiveness  in
patients, and it could be a confounding fac-
tor in BD diagnosis.
66-72
Clinically significant drug intoxications (e.g.
alcohol, barbiturates, sedatives, hypnotics).
CNS-depressant drugs should be ruled out if
the  clinical  history  is  indicative.
55,72-76
Clinicians in the emergency department are
often confronted with coma patients owing
to  poisoning  or  intoxication.  Several
authors  recommend  using  naloxone  in  a
titrated way when an opiate intoxication is
suspected.
77 In the same way, flumazenil has
been advocated as a benzodiazepine antago-
nist in coma of unknown etiology.
77,78
Diagnostic criteria
1. Deep unresponsive coma. The diagnosis
of deep unresponsive coma demands a coma-
tose  patient  showing  a  lack  of  spontaneous
movements in addition to an absence of motor
responses mediated by stimuli applied within
the  cranial  nerve  distribution.
17,22,47,49,53,65 CNS-
mediated motor response to pain in any other
distribution,  seizures,  and  decorticate  and
decerebrate responses impede BD diagnosis.
Some  brain-dead  individuals  may  present
spinal reflexes or motor responses, confined to
spinal distribution, which do not preclude the
BD diagnosis.
22,55,61,62,79,80
2. Absent brainstem reflexes. The reflexes
mediated by the cranial nerves are main indi-
cators of brainstem function. Hence, to prove
their absence is indispensable to BD diagno-
sis. The individual significance of each brain-
stem reflex varies in BD diagnosis according to
an  intrinsic  sensitivity  of  the  cranial  nerve
networks and to the effect of some accompany-
ing  factors  in  brain-dead  patients,  such  as
trauma,  local  edema,  dried  tissues,  and
intracranial tubes affecting the exploration of
reflexes.
17,79
Pupillary reflex. This reflex, direct and con-
sensual, is considered one of the most dis-
criminant  reflexes  in  BD  diagno-
sis.
17,22,55,57,61,62,79,81 Mydriatic, small, or medium-
sized  pupils  are  found  in  brain-dead
cases.
17,43,63,64
Corneal reflex. Unilateral corneal stimula-
tion with a throat swab induces a bilateral
closure of the eyelids, is an easy response to
elicit  and,  if  present,  is  readily  observed.
This is also one of the most discriminant
reflexes in BD diagnosis. A bilateral or uni-
lateral  response  of  eyelid  closure  and
upward deviation of the eye (Bell’s phenom-
enon) indicates preserved brainstem func-
tioning.  However,  edema  or  drying  of  the
cornea, and severe facial and ocular trauma
may preclude a satisfactory stimulus for this
reflex. Moreover, the threshold for excita-
tion decreases markedly if the lids are kept
closed.
1,4,17,22,47,79,82,83
Oculo-cephalic  and  oculo-vestibular
responses. The  oculocephalic  reflex,  also
known as Doll’s eyes response, is elicited
upon brisk turning of the head from middle
position to 90° on both sides. In comatose
patients without lesions of the brainstem,
the eyes normally conjugately deviate to the
other  side.  In  BD  no  eye  movements  are
observed. The neural pathways of this reflex
are  mediated  through  arcs  involving  the
vestibular mechanisms, medial longitudinal
bundle, and ocular nerves. This is a reflex
easy to obtain and moderately discrimina-
tive. The oculo-vestibular response is elicit-
ed by irrigating the tympanum in both sides
with iced water. In a comatose patient with-
out lesions of the medial longitudinal bun-
dle,  and/or  ocular  nerves,  the  elicited
response  is  a  slow  deviation  of  the  eyes
directed  to  the  cold  caloric  stimulus.  The
head of the patient should be elevated 30°
above the horizontal plane, and 50 cc of iced
water is irrigated into the external auditory
canal using a small suction catheter. To con-
firm lack of eye movement may be very diffi-
cult; it has been suggested pen marks are
placed on the lower eyelid at the level of the
pupil to facilitate the detection of slight eye
movements. The examiner should observe
for one minute after irrigation, and wait an
interval of five minutes before stimulating
Article
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examiner confirm that the external auditory
foramen  and  tympanic  membrane  are
undamaged, because clotted blood or ceru-
men  in  the  external  auditory  canal  may
impair this response. Moreover, a rupture of
the  eardrum  usually  augments  caloric
responses. The presence of severe facial and
ocular trauma, eyelid edema, and chemosis
of the conjunctiva may limit movement of
the globes, making it very difficult to elicit
and observe eye movements. Basal fracture
of  the  petrous  bone  abolishes  the  caloric
response unilaterally and may be identified
by the presence of an ecchymotic mastoid
process (Battle’s sign). There are also some
drugs that can lessen this reflex, such as tri-
cyclic  antidepressants,  aminoglycosides,
antiepileptic  drugs,  anticholinergics,  and
chemotherapeutic agents, etc.
1,6,48,62
Gag and cough  response. Pharyngeal (gag),
cough,  and  swallowing  reflexes  are  often
difficult to explore because of the presence
of tubes in the throat and dryness of the
mucosa.  Hence,  in  suspected  brain-dead
cases  the  cough  response  is  usually
explored by passing a catheter through the
endotracheal tube and suctioning with neg-
ative pressure for several seconds. As these
reflexes have their arcs through the medul-
la  oblongata,  it  is  desirable  to  explore
them.
17,22,64,84
3. Negative atropine test. The atropine test
(AtT) assesses bulbar parasympathetic activity
on  heart  activity  in  brain-dead  patients.
85
Ouaknine  first  proposed  including  this  as  a
criterion for the so-called brainstem death.
85-89
The method for this test consists in injecting 2
mg atropine under continuous monitoring of
the ECG during 10 minutes. The AtT is consid-
ered negative if heart rate is not augmented by
more  than  3%  compared  with  basal  ECG
records.
1,58,86,90-95
4. Absent respiratory effort confirmed by the
apnea test. The apnea test (AT) has been con-
sidered by some authors as the “condition sine
qua non” for determining BD, because it pro-
vides an essential sign of a definitive loss of
brainstem  functions.  Nonetheless,  several
authors  have  expressed  their  concern  about
the safety of this procedure, owing to potential
complications  such  as  severe  hypotension,
pneumothorax, excessive hypercarbia, hypox-
ia,  acidosis,  cardiac  arrhythmia,  or  asystole,
which may constrain the examiner to abort the
test,  thereby  compromising  BD  diagnosis.
Nevertheless, when an appropriate oxygen-dif-
fusion  procedure  is  used,  this  technique  is
safe.
1,96-105
5. Periods of observation. If BD determina-
tion is only based on clinical evaluation, the
following periods of observation were proposed
by the Cuban Commission.
1,49-52
Six hours at least, if a structural and irre-
versible CNS insult can be demonstrated by
clinical and neuroimaging evidences.
In  cases  of  acute  hypoxic-ischemic  brain
injury, clinical evaluation should be delayed
for 24 hours subsequent to the cardio-resp-
iratory arrest, or an ancillary test could be
performed.
Periods  of  observation  can  be  shortened
according to medical criteria by the application
of confirmatory tests, to demonstrate a com-
plete  cessation  of  brain  circulation,  or  to
demonstrate loss of bioelectrical activity.
Confirmatory tests
It is widely accepted that BD is a clinical
diagnosis, and currently it is defined as a com-
plete and irreversible loss of brain function.
Confirmatory laboratory tests are recommend-
ed when specific components of the clinical
testing  cannot  be  evaluated  reliably.
50,51,106
Sometimes  the  apnea  test  cannot  be  per-
formed or it must be interrupted by the exam-
iner. Eye injuries may impede an appropriate
assessment of pupillary, corneal, or vestibulo-
reflex testing. In those patients with perforat-
ed  tympanic  membranes  iced  water  caloric
irrigation  for  exploring  the  vestibulo-ocular
reflexes is proscribed. Furthermore, the diag-
nosis of BD in children and neonates is more
complicated  and  usually  ancillary  tests  are
advocated.
57,98,107-111
Confirmatory  tests  are  recommended  to
shorten  periods  of  observation  according  to
physicians’  criteria  and  in  those  conditions
interfering with the clinical BD diagnosis. The
Cuban  Commission  proposed  that  confirma-
tory  tests  should  be  mandatory  in  cases  of
patients  with  primary  brainstem  lesions
undergoing BD diagnosis.
1,49-51
Confirmatory tests in BD can be divided into
those  proving  absent  CBF  and  those  that
demonstrate loss of bioelectrical activity. 
Tests to demonstrate absent cere-
bral blood flow
Bernat recently emphasized that “the most
confident way to demonstrate that the global
loss of clinical brain functions is irreversible is
to show the complete absence of intracranial
blood flow.”
112 Ingvar and colleagues defended
this, concluding that the permanent cessation
of CBF produces total brain infarction.
113,114
Several tests that can measure CBF accur-
ately  and  validly  in  suspected  brain-dead
patients  have  been  developed  in  the  last
decades. The first technique used to demon-
strate absence of intracranial circulation in BD
distal to the intracranial portions of the inter-
nal carotid and vertebral arteries was cerebral
angiography.
115-117 Other  techniques  used  to
determine  absent  CBF  have  been:  cerebral
intravenous  digital  subtraction  angiography,
intravenous radionuclide angiography, single
photon  emission  tomography  (SPECT),
echoencephalography,  measurement  of  arm-
to-retina  circulation  time,  ophthalmic  artery
pressure measurement, xenon-enhanced com-
puted  tomography,  MRI  angiography,  CT
angiography and CT perfusion, and transcra-
nial Doppler ultrasonography (TCD). 
Although it has not been widely used as an
ancillary test in BD, the 18F-FDG PET scan has
been used by some authors to study brain-dead
patients,  and  confirmed  no  intracerebral
uptake or retention of tracer, consistent with a
diffuse absence of brain metabolism.
118,119
Another technique that could be useful in
monitoring biochemical changes in vivo, from
coma  to  BD,  is  proton  magnetic  resonance
spectroscopy  (1H-MRS).  N-acetyl  aspartate
(NAA)  content  is  a  measure  of  neuronal
integrity, choline (Cho) content mirrors mem-
brane turnover, and creatine (Cre) relates to
energy dependent systems. Falini et al. serially
studied a patient with severe global hypoxic-
ischemic  brain  injury  using  1H-MRS.
Particularly notable was a quick decline of NAA
in the acute phase, suggesting the severity of
the neuronal insult, and after seven weeks of
evolution the irreversible death of the major
part  of  the  neuronal  population  was  con-
firmed.
120 We have also applied this technique
to monitor metabolic changes in the evolution
from a persistent vegetative state to a mini-
mally conscious state.
121
TCD has been recommended for assessing
CBF in suspected brain-dead patients.
122-128 TCD
is a noninvasive technique that measures local
blood flow velocity and direction in the proxi-
mal portions of large intracranial arteries. TCD
requires training and experience to perform it
and interpret results; hence, it is typified as
operator-dependent.
129,130 In  the  ICU  setting,
intensivists  or  neurologists  usually  receive
training to apply this technique using portable
Doppler devices in suspected brain-dead cases.
Oscillating flow, systolic spikes, or no flow pat-
terns are typical Doppler-sonographic flow sig-
nals found in the presence of cerebral circula-
tory  arrest,  which  if  irreversible,  results  in
BD.
1,131,132
Nonetheless,  recent  reports  affirmed  that
multi-slice CT angiography (CTA) is a robust
tool  to  demonstrate  the  lack  of  intracranial
blood flow, showing a high sensitivity and a
wide safety margin for diagnosing BD. In the
near future it might be the preferred test for
proving CBF.
29,124,133
Tests to demonstrate loss of bio-
electrical activity
The EEG has been closely linked to BD since
the pioneering descriptions of the death of the
nervous system and coma dépassé.
134,135 The set
Article
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those from the Commonwealth countries, does
not include EEG.
3-5,136-140 On the contrary, EEG is
recommended by most countries adopting the
“whole brain death” definition.
141-145
Although EEG is sensitive to hypothermia,
drugs, or extreme hypotension,
146 and several
artifacts can appear in the ICU environment,
this technique is still extensively used as an
ancillary test in BD diagnosis. Buchner et al.
proposed that its sensitivity as well as speci-
ficity  can  reach  up  to  90%.
147 On  the  other
hand, multimodality evoked potentials (MEP)
and  electroretinography  (ERG)  are  highly
resistant  to  drug  intoxication  and  hypother-
mia, and have been shown to be reliable in the
ICU environment.
148-154 Owing to these features,
a substantial interest in multimodality evoked
potentials (MEPs) in BD has grown over the
past two decades, and a wealth of data are now
available  in  the  literature.
151,152,155-159 However,
considered  as  single  tests,  they  have  their 
limitations and they are not included routinely
as  confirmatory  tests  for  BD  diagnosis.
1,160
Hence,  we  have  proposed  to  combine  EEG,
MEP, and ERG in a test battery to study brain-
dead patients in order to increase diagnostic
reliability.
49,152,158,161-168
Therefore,  an  adequate  medical  practice
would be to assess comatose patients by moni-
toring CBF by TCD, and neuronal function by
the above mentioned neurophysiologic test bat-
tery. If TCD fails to validate the absence of CBF,
CTA can be used to confirm BD diagnosis.
1
Brain death and organ 
transplants
Although  it  is  commonly  believed  that  the
concept of BD was developed to benefit organ
transplants,  it  evolved  independently.  Trans-
plantation owed its development to advances in
surgery and immunosuppressive treatment; BD
owed its origin to the development of intensive
care. A historical review demonstrates that the
BD  concept  and  organ  transplantation  arose
separately and advanced in parallel, and only
began to progress together in the late 1960s.
5-
8,11,12,169,170 Of  course,  organ  procurement  pro-
grams have induced a tie relationship between
organ  transplants  and  BD  diagnosis  in  most
countries and, hence, it is extremely important
to  educate  the  public  to  understand  that  BD
means death of the individual, and of the impor-
tance of organ donation for transplants. 
Conclusions
BD  should  be  understood  as  the  ultimate
clinical expression of a brain catastrophe lead-
ing to a complete and irreversible neurological
stoppage, characterized by irreversible coma,
absent brainstem reflexes, and apnea. We have
enumerated three possible situations for diag-
nosing death based on the “signs of death”.
This methodology of diagnosing death does not
mean that there are different types of death.
The irreversible loss of cardio-circulatory and
respiratory  functions  can  cause  death  only
when  ischemia  and  anoxia  are  prolonged
enough to produce an irreversible destruction
of the brain. 
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